Recommendations by the Drug Review Committee
Reviewed in October 2008 -Anti-diabetic medications
Reviewed in August 2008 -ARBs
Reviewed in June 2008 -Long Acting Opioids
Reviewed in April 2008 -Hormone Replacement Therapy
Reviewed in March 2008 -Statins Reviewed in February 2008 -Neuropathic Pain Medications Reviewed in January 2008 -Proton Pump Inhibitors Reviewed in November 2007 -Antihistamines Reviewed in October 2007 -ACE Inhibitors Reviewed in September 2007 -Beta Blockers Reviewed in July 2007 -Calcium Channel Blockers and Targeted Immune Modulators Reviewed in June 2007 - Antimigraine "Triptan" Medications
Reviewed in May 2007 - Proton Pump Inhibitors (revisted January 2008)
Reviewed in April 2007 - ADHD Medications
Reviewed in March 2007 - NSAIDS
Reviewed in February 2007 - Beta2 Agonists
Reviewed in December 2006 - Second Generation Antidepressants
Reviewed in August 2006 - Anti-Diabetic Meds
Reviewed in June 2006 - Antiemetics
Reviewed in May 2006 - Agents for Overactive Bladder
Reviewed in April 2006 - Inhaled Corticosteroids
Reviewed in March 2006 - Targeted Immune Modulators
Reviewed in February 2006 - Newer Sedative Hypnotics
Reviewed in January 2006 - Estrogens
Reviewed in December 2005 - Skeletal Muscle Relaxants
Reviewed in November 2005 - Angiontensin II Receptor Blockers (ARBs) (revisted October 2007, August 2008)
Reviewed in October 2005 - Antimigraine "Triptan" Medications (revisited June 2007)
Reviewed in September 2005 - Antiplatelet Agents
Reviewed in August 2005 - ACE Inhibitors
Reviewed in July 2005 - Long Acting Opioids
Reviewed in June 2005 - Beta Blockers(revisted September 2007)
Reviewed in May 2005 - Inhaled Corticosteroids
Reviewed in April 2005 - Calcium Channel Blockers
Reviewed in March 2005 - HMG Co-A Reductase Inhibitor "Statin" Medications (revisited in March 2008)
Reviewed in February 2005 - Proton Pump Inhibitors (Revisted January 2008)
Reviewed in January 2005 - Non-sedating Antihistamines (revisted November 2007)
To open these files you will need Adobe Acrobat Reader.  | 